Article Details

Daiichi Sankyo, AstraZeneca Dose First Gastric Cancer Patient in Phase III Enhertu Trial

Retrieved on: 2021-07-09 15:11:15

Tags for this article:

Click the tags to see associated articles and topics

Daiichi Sankyo, AstraZeneca Dose First Gastric Cancer Patient in Phase III Enhertu Trial. View article details on hiswai:

Excerpt

NEW YORK – Daiichi Sankyo and AstraZeneca said on Friday that investigators have dosed the first HER2-positive, advanced gastric cancer patient ...

Article found on: www.precisiononcologynews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up